News

Filter

Current filters:

PharmaceuticalChina

1 to 9 of 92 results

Lilly and Innovent collaborate to bring potential cancer drugs to market

20-03-2015

US pharma major Eli Lilly has joined forces with Innovent Biologics, a leading Chinese biotech firm,…

ChinaEli LillyGlobalInnovent BiologicsLicensingOncologyPharmaceuticalResearch

USA rapidly losing bioscience research market share to Asia

USA rapidly losing bioscience research market share to Asia

18-03-2015

The latest data from antibody search engine CiteAb suggests that the USA has continued to lose its share…

ChinaIndiaPharmaceuticalResearchUSA

Sinovac issues update on pipeline

Sinovac issues update on pipeline

17-03-2015

Chinese biopharma company Sinovac has issued an update on its pipeline, namely that the EV71 vaccine…

ChinaPharmaceuticalResearchSinovacVaccines

GSK dismisses 110 employees in Chinese bribery scandal

GSK dismisses 110 employees in Chinese bribery scandal

09-03-2015

UK pharma major GlaxoSmithKline has reportedly sacked more than 100 employees in China due to misconduct…

BloombergChinaGSKPharmaceuticalRegulation

Drug companies face competition in China as price control reforms begin

Drug companies face competition in China as price control reforms begin

06-03-2015

Pharma price controls in China could come to an end as the government’s strategy to reform access to…

ChinaPharmaceuticalPharmacologyPricingSouth China Morning Post

China regulates hospital drug purchasing

02-03-2015

A document on hospital drug purchasing in China was released Saturday, which instructed that hospitals…

ChinaFinancialHealthcarePharmaceutical

Colorectal cancer drug market in China set to grow nearly four-fold by 2023; report

Colorectal cancer drug market in China set to grow nearly four-fold by 2023; report

18-02-2015

The Chinese treatment market for colorectal cancer (CRC) will expand almost fourfold in value from an…

AmgenBayerChinaLonsurfMarkets & MarketingOncologyPharmaceuticalSanofiStivargaTaiho PharmaceuticalTakeda PharmaceuticalVectibixZaltrap

UCB’s Phase III results for Neupro will back filing in China this year

UCB’s Phase III results for Neupro will back filing in China this year

05-02-2015

Belgian drugmaker UCB has announced positive top-line results from two Phase III studies of Neupro (rotigotine…

ChinaNeuproNeurologicalPharmaceuticalResearchUCB

1 to 9 of 92 results

Back to top